These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 10911911)

  • 1. The epigenetics of colorectal cancer.
    Issa JP
    Ann N Y Acad Sci; 2000 Jun; 910():140-53; discussion 153-5. PubMed ID: 10911911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CpG island methylator phenotype in colorectal cancer.
    Toyota M; Ahuja N; Ohe-Toyota M; Herman JG; Baylin SB; Issa JP
    Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8681-6. PubMed ID: 10411935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline, somatic and epigenetic events underlying mismatch repair deficiency in colorectal and HNPCC-related cancers.
    Yuen ST; Chan TL; Ho JW; Chan AS; Chung LP; Lam PW; Tse CW; Wyllie AH; Leung SY
    Oncogene; 2002 Oct; 21(49):7585-92. PubMed ID: 12386821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency.
    Dawson H; Galván JA; Helbling M; Muller DE; Karamitopoulou E; Koelzer VH; Economou M; Hammer C; Lugli A; Zlobec I
    Int J Cancer; 2014 May; 134(10):2342-51. PubMed ID: 24166180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between point gene mutation, chromosomal abnormality, and tumour suppressor gene methylation status in colorectal adenomas.
    Judson H; Stewart A; Leslie A; Pratt NR; Baty DU; Steele RJ; Carey FA
    J Pathol; 2006 Nov; 210(3):344-50. PubMed ID: 16902913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma.
    Herman JG; Umar A; Polyak K; Graff JR; Ahuja N; Issa JP; Markowitz S; Willson JK; Hamilton SR; Kinzler KW; Kane MF; Kolodner RD; Vogelstein B; Kunkel TA; Baylin SB
    Proc Natl Acad Sci U S A; 1998 Jun; 95(12):6870-5. PubMed ID: 9618505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1.
    Fleisher AS; Esteller M; Harpaz N; Leytin A; Rashid A; Xu Y; Liang J; Stine OC; Yin J; Zou TT; Abraham JM; Kong D; Wilson KT; James SP; Herman JG; Meltzer SJ
    Cancer Res; 2000 Sep; 60(17):4864-8. PubMed ID: 10987299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype.
    Toyota M; Ohe-Toyota M; Ahuja N; Issa JP
    Proc Natl Acad Sci U S A; 2000 Jan; 97(2):710-5. PubMed ID: 10639144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics supersedes epigenetics in colon cancer phenotype.
    Yamashita K; Dai T; Dai Y; Yamamoto F; Perucho M
    Cancer Cell; 2003 Aug; 4(2):121-31. PubMed ID: 12957287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma.
    An C; Choi IS; Yao JC; Worah S; Xie K; Mansfield PF; Ajani JA; Rashid A; Hamilton SR; Wu TT
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):656-63. PubMed ID: 15701853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability.
    Cunningham JM; Christensen ER; Tester DJ; Kim CY; Roche PC; Burgart LJ; Thibodeau SN
    Cancer Res; 1998 Aug; 58(15):3455-60. PubMed ID: 9699680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redundant DNA methylation in colorectal cancers of Lynch-syndrome patients.
    Alemayehu A; Sebova K; Fridrichova I
    Genes Chromosomes Cancer; 2008 Oct; 47(10):906-14. PubMed ID: 18618713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression.
    Deng G; Chen A; Hong J; Chae HS; Kim YS
    Cancer Res; 1999 May; 59(9):2029-33. PubMed ID: 10232580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic Risk Factor Distributions for MLH1 Promoter Region Methylation in CIMP-Positive Tumors.
    Levine AJ; Phipps AI; Baron JA; Buchanan DD; Ahnen DJ; Cohen SA; Lindor NM; Newcomb PA; Rosty C; Haile RW; Laird PW; Weisenberger DJ
    Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):68-75. PubMed ID: 26512054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variants of methyl metabolizing enzymes and epigenetic regulators: associations with promoter CpG island hypermethylation in colorectal cancer.
    de Vogel S; Wouters KA; Gottschalk RW; van Schooten FJ; de Goeij AF; de Bruïne AP; Goldbohm RA; van den Brandt PA; Weijenberg MP; van Engeland M
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3086-96. PubMed ID: 19843671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative role of methylator and tumor suppressor pathways in ulcerative colitis-associated colon cancer.
    Sanchez JA; Dejulius KL; Bronner M; Church JM; Kalady MF
    Inflamm Bowel Dis; 2011 Sep; 17(9):1966-70. PubMed ID: 21618350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of DNA methylation status analyzed by bisulfite-PCR-SSCP and correlation with clinico-pathological characteristics in colorectal cancer.
    Maekawa M; Sugano K; Ushiama M; Fukayama N; Nomoto K; Kashiwabara H; Fujita S; Kakizoe T
    Clin Chem Lab Med; 2001 Feb; 39(2):121-8. PubMed ID: 11341745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-resolution methylation analysis of the hMLH1 promoter in sporadic endometrial and colorectal carcinomas.
    Strazzullo M; Cossu A; Baldinu P; Colombino M; Satta MP; Tanda F; De Bonis ML; Cerase A; D'Urso M; D'Esposito M; Palmieri G
    Cancer; 2003 Oct; 98(7):1540-6. PubMed ID: 14508843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concerted promoter hypermethylation of hMLH1, p16INK4A, and E-cadherin in gastric carcinomas with microsatellite instability.
    Kim H; Kim YH; Kim SE; Kim NG; Noh SH; Kim H
    J Pathol; 2003 May; 200(1):23-31. PubMed ID: 12692837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype.
    Toyota M; Ahuja N; Suzuki H; Itoh F; Ohe-Toyota M; Imai K; Baylin SB; Issa JP
    Cancer Res; 1999 Nov; 59(21):5438-42. PubMed ID: 10554013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.